PHARMACIA AND UPJOHN FDA Approval NDA 020465

NDA 020465

PHARMACIA AND UPJOHN

FDA Drug Application

Application #020465

Documents

Letter2021-11-02

Application Sponsors

NDA 020465PHARMACIA AND UPJOHN

Marketing Status

Prescription001

Application Products

001TABLET; ORAL500MG0AZULFIDINESULFASALAZINE

FDA Submissions

TYPE 6; Type 6 - New Indication (no longer used)ORIG1AP1996-10-17STANDARD

CDER Filings

PHARMACIA AND UPJOHN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20465
            [companyName] => PHARMACIA AND UPJOHN
            [docInserts] => ["",""]
            [products] => [{"drugName":"AZULFIDINE","activeIngredients":"SULFASALAZINE","strength":"500MG","dosageForm":"TABLET; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AZULFIDINE","submission":"SULFASALAZINE","actionType":"500MG","submissionClassification":"TABLET; ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.